Moderna mRNA Flu Vaccine Effective, FDA Reviewers Say

Regulators are considering whether to clear the first messenger ribonucleic acid vaccine against influenza.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

Moderna’s messenger ribonucleic acid (mRNA) influenza vaccine is effective, but uncertainties remain, Food and Drug Administration reviewers said in a document released on June 16.

Data from a Phase 3 trial show the mRNA vaccine, known as mRNA-1010, had a “clinical benefit,” the reviewers said in the 92-page document.